PBX1 and myeloproliferative neoplasm: In certain MPN patients with the JAK2V617F mutation, an alteration in the copy number of PBX1 was seen [42], accompanied by elevated expression levels in CD34+ cells in Polycythemia Vera (PV) patients [43].